Stay updated with breaking news from Breakthrough Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Helius Medical Technologies Inc has received Breakthrough Designation from the US Food and Drug Administration for its PoNS device as a temporary treatment of dynamic gait and balance deficits due to symptoms from stroke, it announces.
CartiHeal succeeds in clinical trial for cartilage treatment CartiHeal is on a Breakthrough Therapy fast track for FDA approval, and US company Bioventus has an option to acquire it. Israeli company CartiHeal has announced success in a clinical trial of its treatment for knee cartilage damaged either by injury or by arthritis. The company reported that its cartilage substitute product was more successful than the currently used treatments. The trial involved 251 patients, and was conducted over two years. Among the investors in CartiHeal are Elron Electronic Industries Ltd. (TASE: ELRN), with...
and Corresponding Risk Reduction Over Time NEW YORK, June 28, 2021 - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces new data demonstrating KidneyIntelX™ can be effective at monitoring therapeutic response and improvements in kidney health over time in adults with type 2 diabetes. By accurately assessing therapeutic response, particularly in patients at high risk for kidney failure, KidneyIntelX can potentially address a major barrier for primary care physicians and specialists in using new pharmaceuticals to slow kidney...
/PRNewswire/ -- Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve cost, efficiency, and...
/PRNewswire/ -- miR Scientific, LLC, a healthcare company dedicated to transforming global cancer management by providing early and highly accurate detection,...